BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:38 PM
 | 
Oct 08, 2012
 |  BC Extra  |  Company News

Vaxxas, Merck in vaccine deal

Vaxxas Pty. Ltd. (Sydney, Australia) granted Merck & Co. Inc. (NYSE:MRK) exclusive, worldwide rights to develop and commercialize a vaccine using Vaxxas'...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >